Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562.
作者信息
Hoffman R, Graham L, Newlands E S
机构信息
Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross Hospital, London, UK.
出版信息
Br J Cancer. 1989 Mar;59(3):347-8. doi: 10.1038/bjc.1989.68.
Abstract
摘要
相似文献
1
Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562.槲皮素增强白消安对人白血病细胞系K562的抗增殖作用。
Br J Cancer. 1989 Mar;59(3):347-8. doi: 10.1038/bjc.1989.68.
2
Concentration and effect of quercetin.槲皮素的浓度与作用
Exp Hematol. 1996 Mar;24(4):494-6.
3
The combined use of busulfan and hydroxyurea in the treatment of chronic myeloid leukemia.白消安与羟基脲联合用于慢性髓性白血病的治疗。
Hawaii Med J. 1990 Apr;49(4):133-4.
4
Cotreatment with vorinostat (suberoylanilide hydroxamic acid) enhances activity of dasatinib (BMS-354825) against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells.伏立诺他（辛二酰苯胺异羟肟酸）与达沙替尼（BMS-354825）联合治疗可增强达沙替尼对甲磺酸伊马替尼敏感或甲磺酸伊马替尼耐药的慢性粒细胞白血病细胞的活性。
Clin Cancer Res. 2006 Oct 1;12(19):5869-78. doi: 10.1158/1078-0432.CCR-06-0980.
5
Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.丙戊酸钠通过 SIRT1 增强伊马替尼对慢性髓系白血病细胞的抗白血病作用。
Cancer Lett. 2015 Jan 28;356(2 Pt B):791-9. doi: 10.1016/j.canlet.2014.10.033. Epub 2014 Oct 31.
6
Synergistic Induction of Apoptosis by Quercetin and Curcumin in Chronic Myeloid Leukemia (K562) Cells.槲皮素和姜黄素协同诱导慢性粒细胞白血病（K562）细胞凋亡
Nutr Cancer. 2018 Jan;70(1):97-108. doi: 10.1080/01635581.2018.1380208. Epub 2017 Nov 21.
7
Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.用于髓系恶性肿瘤自体移植前的白消安和马法兰。
Bone Marrow Transplant. 1995 Jul;16(1):69-70.
8
Mitoxantrone & adriamycin cytotoxicity enhanced by reserpine in human chronic myeloid leukaemia cells.利血平增强米托蒽醌和阿霉素对人慢性髓性白血病细胞的细胞毒性。
Indian J Med Res. 1989 Jun;90:197-202.
9
Pregnancy in a patient receiving busulphan for chronic myeloid leukaemia.
Singapore Med J. 1994 Feb;35(1):102-3.
10
Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.在慢性髓性白血病细胞中，Cdc6作为BCR/ABL依赖性生存因子的表达失调。
Tumour Biol. 2017 Jun;39(6):1010428317713394. doi: 10.1177/1010428317713394.
引用本文的文献
1
Flavonoids as Chemosensitizers in Leukemias.黄酮类化合物作为白血病的化学增敏剂
Adv Exp Med Biol. 2025;1479:205-234. doi: 10.1007/5584_2024_828.
2
Anti-Proliferative Effects of Dendrophthoe pentandra Methanol Extract on BCR/ABL-Positive and Imatinib-Resistant Leukemia Cell Lines.小叶黑面神甲醇提取物对BCR/ABL阳性及伊马替尼耐药白血病细胞系的抗增殖作用
Asian Pac J Cancer Prev. 2016 Nov 1;17(11):4857-4861. doi: 10.22034/APJCP.2016.17.11.4857.
3
PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy.分别负载依托泊苷和二水槲皮素的聚乳酸-羟基乙酸共聚物纳米颗粒：体外细胞系研究以确保联合治疗的优势
Cancer Nanotechnol. 2012;3(1-6):25-36. doi: 10.1007/s12645-012-0027-y. Epub 2012 May 9.
4
Chemotherapy and dietary phytochemical agents.化疗与膳食植物化学剂。
Chemother Res Pract. 2012;2012:282570. doi: 10.1155/2012/282570. Epub 2012 Dec 20.
5
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells.槲皮素对OVCA 433细胞的抑制作用以及原发性卵巢肿瘤和培养细胞中II型雌激素结合位点的存在。
Br J Cancer. 1990 Dec;62(6):942-6. doi: 10.1038/bjc.1990.414.
6
Role of protein kinase C in adriamycin-induced erythroid differentiation of K562 cells.
Cancer Chemother Pharmacol. 1991;28(2):102-4. doi: 10.1007/BF00689696.
7
Quercetin induces recombinational mutations in cultured cells as detected by DNA fingerprinting.通过DNA指纹图谱检测发现，槲皮素可在培养细胞中诱导重组突变。
Jpn J Cancer Res. 1991 Oct;82(10):1061-4. doi: 10.1111/j.1349-7006.1991.tb01757.x.
8
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites.槲皮素抑制表达II型雌激素结合位点的多药耐药雌激素受体阴性MCF-7人乳腺癌细胞系的生长。
Cancer Chemother Pharmacol. 1991;28(4):255-8. doi: 10.1007/BF00685531.
本文引用的文献
1
Phospholipid-sensitive Ca2+-dependent protein phosphorylation system in various types of leukemic cells from human patients and in human leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid.人类患者各类白血病细胞以及人白血病细胞系HL60和K562中的磷脂敏感型钙依赖性蛋白磷酸化系统，及其被烷基溶血磷脂抑制的情况。
Cancer Res. 1983 Jun;43(6):2955-61.
2
Inhibition of the calcium- and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin.槲皮素对小鼠脑细胞溶胶中钙和磷脂依赖性蛋白激酶活性的抑制作用。
Biochem Biophys Res Commun. 1983 Dec 16;117(2):444-7. doi: 10.1016/0006-291x(83)91220-2.
3
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.剂量-效应关系的定量分析：多种药物或酶抑制剂的联合效应
Adv Enzyme Regul. 1984;22:27-55. doi: 10.1016/0065-2571(84)90007-4.
4
The effect of quercetin on the phosphorylation activity of the Rous sarcoma virus transforming gene product in vitro and in vivo.槲皮素对劳氏肉瘤病毒转化基因产物在体外和体内磷酸化活性的影响。
Eur J Biochem. 1983 Oct 3;135(3):583-9. doi: 10.1111/j.1432-1033.1983.tb07692.x.
5
Perturbation of in vitro drug resistance in human lymphatic neoplasms by combinations of putative inhibitors of protein kinase C.蛋白激酶C假定抑制剂联合使用对人淋巴瘤体外耐药性的影响
Cancer Treat Rep. 1987 Dec;71(12):1239-43.
6
7
Triphenylethylenes: a new class of protein kinase C inhibitors.
J Natl Cancer Inst. 1986 Jun;76(6):1243-6.
8
9
Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.用普卡霉素和羟基脲治疗慢性粒细胞白血病髓系原始细胞期的初步观察
N Engl J Med. 1986 Dec 4;315(23):1433-8. doi: 10.1056/NEJM198612043152301.
10
Disposition of quercetin in man after single oral and intravenous doses.单次口服和静脉给药后槲皮素在人体内的处置情况。
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):229-34. doi: 10.1007/BF00614022.
Zotero 插件